Leukemia & Lymphoma

Papers
(The H4-Index of Leukemia & Lymphoma is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
The prognostic role of gene polymorphisms in patients with indolent non-Hodgkin lymphomas and mantle-cell lymphoma receiving bendamustine and rituximab: results of the 5-year follow-up study50
Impact of SF3B1 mutation in myelofibrosis45
Pulmonary infections in patients with acute myeloid leukemia receiving frontline treatment with hypomethylating agents31
CD274 structural variants for guiding treatment with PD-1 blockade in a patient with relapsed/refractory chronic active EBV transformed to NK lymphoma29
Evaluating early response assessment in extranodal natural killer/T-cell lymphoma by analyzing ΔSUVlbm between baseline and interim 18 F-FDG PET/CT scans27
Treatment outcomes of venetoclax-combination regimens for relapsed/refractory myeloid malignancies after anti-CD47-directed therapy26
Risk factors for mortality and re-admission of children with hematological malignancies to the intensive care unit due to sepsis23
Real-world associations of cytokine release syndrome and neurotoxicity with efficacy in patients receiving anti-CD-19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: the Mayo Clini23
Organ toxicities associated with chimeric antigen receptor T-cell therapy22
The effect of the plasma methotrexate concentration during high-dose methotrexate therapy in childhood acute lymphoblastic leukemia22
Incidence of major bleeding in patients with chronic lymphocytic leukemia receiving ibrutinib and therapeutic anticoagulation20
Hypereosinophilia after CAR T-cell therapy18
Shift in first-line therapies for United States Veterans Affairs (VA) patients with chronic lymphocytic leukemia (CLL)18
Complete remission in a case of acute undifferentiated leukemia with novel combination therapy of FLAG-IDA and venetoclax18
Risk factors for the development of orthostatic hypotension during autologous stem cell transplant in patients with multiple myeloma17
Indolent B-cell non-Hodgkin lymphomas in children: high association with inborn errors of immunity17
The inherited genetic contribution and polygenic risk score for risk of CLL and MBL: a narrative review16
Use of PD-1 blockade in refractory/relapsed natural killer T-cell lymphomas: a systematic review and synthesis of case reports16
0.103276014328